FDA Brief

Company record

Granules Pharmaceuticals Inc.

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about Granules Pharmaceuticals Inc..

Recalls

ReportedClassFirmProduct and reason
Feb 11 Class II Granules Pharmaceuticals Inc.
Drug
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.
Presence of Foreign Tablets/Capsules
FDA notice D-0305-2026